Completed
PHASE3
INTERVENTIONAL
NCT03148574
Intrauterine Misoprostol Versus Intravenous Oxytocin Infusion During Cesarean Delivery
View on ClinicalTrials.gov
Updated Dec 15, 2025
Brief Summary
Bleeding is still the major cause of mortality and morbidity in postpartum period. World health organization has reported 585000 deaths for pregnancy each year. Twenty five percent of cases die from post-partum bleeding. Mean amount of blood lost is 500 ml during normal vaginal delivery, 1000 ml in cesarean section, and 3500 ml during cesarean section with emergency hysterectomy
Interventions
Name:
Misoprostol
Type:
DRUG
Description:
intrauterine tablets
Name:
Oxytocin
Type:
DRUG
Description:
intravenous
Primary Outcomes
Measure:
amount of intraoperative blood loss
TimeFrame:
30 minutes
Description:
Trial Information
NCT ID
NCT03148574
Status
Completed
Study Type
INTERVENTIONAL
Phases
PHASE3
Sponsor
Assiut University
Last Updated
December 15, 2025